0. DOCID:23616 SCORE: 0.00204735583186001
DOCNO: 8979633
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: prevention & control
AUTHOR: P B Desai PB
PUBTYPE: Journal Article
JOURNALTITLE: Indian journal of medical sciences.
COUNTRY: INDIA
TITLE: Cancer control in the Asia Pacific region--the next lap.
PUBDATE: 19960201
Cancer control in any part of the world has to be a multi-directional effort addressed in a holistic manner. The general impression that cancer control means only collation of epidemiological data and efforts at primary prevention needs to be redefined because preventive and educative oncology, though an important component of cancer control, can achieve long-term goals only after 20 years or more. Along with such long-term objectives, methodology needs to be developed which takes care of immediate and recent needs in early diagnosis, effective treatment, and appropriate basic research for the ultimate control and cure of cancer. A holistic approach to the cancer control effort will, therefore, need the combined skills of many different specialists.


1. DOCID:20479 SCORE: 0.00203218791357207
DOCNO: 9447659
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Betaretrovirus
QUALIFIER: virology
QUALIFIER: virology
AUTHOR: M Palmarini M
AUTHOR: H Fan H
AUTHOR: J M Sharp JM
AFFILIATION: Cancer Research Institute, University of California Irvine 92697, USA. massimo@darwin.bio.uci.edu
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Trends in microbiology.
COUNTRY: ENGLAND
TITLE: Sheep pulmonary adenomatosis: a unique model of retrovirus-associated lung cancer.
PUBDATE: 19971201
Sheep pulmonary adenomatosis (SPA) is a contagious bronchiolo-alveolar carcinoma of sheep associated with an exogenous type D/B retrovirus known as jaagsiekte sheep retrovirus (JSRV). SPA represents a unique model for lung cancer, and studies on its aetiopathogenesis can provide further insight into the mechanisms of epithelial neoplasms.


2. DOCID:23662 SCORE: 0.00190985781945514
DOCNO: 7622109
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: utilization
QUALIFIER: radiotherapy
AUTHOR: A P Polednak AP
AFFILIATION: Connecticut Tumor Registry, Connecticut Department of Public Health and Addiction Services, Hartford 06106, USA.
PUBTYPE: Journal Article
JOURNALTITLE: Gynecologic oncology.
COUNTRY: UNITED STATES
TITLE: Declining use of radiotherapy for invasive cervical cancer in Connecticut: 1983-1990.
PUBDATE: 19950801
Data on the use of radiotherapy (i.e., external irradiation and/or intracavitary radioactive implants) in the first course of treatment were examined for all 1286 invasive cervical cancer cases diagnosed between 1983 and 1990 among Connecticut residents. These data, from a population-based cancer registry, reflect actual treatment practices in the geographic area under study. Use of radiotherapy declined from 62% in 1983 to 43% in 1990 (trend test P < 0.001); for "local"-stage cancers, the decline was from 50% in 1983 to 27% in 1990 (P < 0.001). Surveys are needed on physicians' attitudes and decisions regarding alternative treatments for cervical cancer.


3. DOCID:23699 SCORE: 0.00190985524122149
DOCNO: 8618397
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapy
QUALIFIER: therapy
AUTHOR: P Kelty P
AUTHOR: H Frazier H
AUTHOR: K O'Connell K
AUTHOR: B C Ghosh BC
AFFILIATION: Department of Urology, National Naval Medical Center, Bethesda, Maryland 20889-5000, USA.
PUBTYPE: Journal Article
JOURNALTITLE: Journal of surgical oncology.
COUNTRY: UNITED STATES
TITLE: Germ cell testis cancer: 15-year review.
PUBDATE: 19960501
Testis cancer affects 2-3 men per every 100,000 in the United States, making it the most common solid tumor of men in the 20-35-year-old age range. Since the average age of active duty military personnel is included in the age range of those at greatest risk for germ cell testis cancer, it is of pertinent clinical importance to physicians who treat these young patients. The National Naval Medical Center has been using cisplatin-based protocols since the time of their introduction. This study reviews the success of treating these patients and examines the treatment failures.


4. DOCID:20940 SCORE: 0.00189533045288505
DOCNO: 9270709
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: prevention & control
QUALIFIER: prevention & control
QUALIFIER: therapeutic use
AUTHOR: M Meydani M
AUTHOR: J G Meisler JG
AFFILIATION: Vascular Biology Program, United States Department of Agriculture, Tufts University, Boston, USA.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Postgraduate medicine.
COUNTRY: UNITED STATES
TITLE: A closer look at vitamin E. Can this antioxidant prevent chronic diseases?
PUBDATE: 19970801
Vitamin E, the most effective natural free radical scavenger identified to date, is taking America by storm-and apparently for good reason. Reports of benefits ranging from Improved Immunity to prevention of cancer and cardiovascular disease are appearing regularly. In this article, the authors review the scientific literature to help you evaluate whether patients might benefit from supplemental vitamin E.


5. DOCID:22567 SCORE: 0.00186400026455681
DOCNO: 7604194
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: epidemiology
AUTHOR: S S Devesa SS
AFFILIATION: Descriptive Studies Section, National Cancer Institute, Bethesda, MD 20892, USA.
PUBTYPE: Journal Article
JOURNALTITLE: Seminars in oncology nursing.
COUNTRY: UNITED STATES
TITLE: Cancer patterns among women in the United States.
PUBDATE: 19950501
The American Cancer Society estimated that 576,000 invasive cancers would be diagnosed among American women in 1994 and that 255,000 women will have died of cancer during that year. Six cancers account for almost 70% of the cases in women and more than 60% of the deaths. Risk factors associated with breast, lung, colorectal, cervix uteri, corpus uteri, and ovarian cancers are presented. The patterns of occurrence in the population, time trends, survival rates, and etiologic factors vary considerably, suggesting a constellation of diseases in women. One of the most important factors influencing outcome is early diagnosis.


6. DOCID:21454 SCORE: 0.00179773227004773
DOCNO: 8747797
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: blood
QUALIFIER: blood
QUALIFIER: blood
QUALIFIER: blood
AUTHOR: A A Mihas AA
AUTHOR: R J Maliakkal RJ
AUTHOR: M Shueke M
AUTHOR: J L Achord JL
PUBTYPE: Journal Article
JOURNALTITLE: Research communications in molecular pathology and pharmacology.
COUNTRY: UNITED STATES
TITLE: Serum gastrin levels in patients with colorectal cancer and adenomatous polyps: a prospective study.
PUBDATE: 19951101
Serum gastrin levels were measured by radioimmunoassay in 62 patients with colorectal neoplasms (40 with adenomatous polyps and 22 with cancer) and 40 controls. Fasting serum gastrin in both the polyp (73.93 +/- 6.5 pg/ml) and the cancer (99 +/- 19.7 pg/ml) groups was significantly higher than those of the control group (42.65 +/- 2.2 pg/ml). These findings suggest that hypergastrinemia may be an etiologic factor in colorectal neoplasia.


7. DOCID:22021 SCORE: 0.0017889260760333
DOCNO: 7765800
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Photochemotherapy
AUTHOR: J G Levy JG
AFFILIATION: Quadra Logic Technologies Inc., Vancouver, BC, Canada.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Trends in biotechnology.
COUNTRY: ENGLAND
TITLE: Photodynamic therapy.
PUBDATE: 19950101
Photodynamic therapy (PDT) involves the use of a class of molecules that are activated by light, and which accumulate in, and are retained by, certain abnormal tissues. When these molecules (known as photosensitizers) are activated by light, they cause the formation of active forms of oxygen, which result in the killing of cells in which the photosensitizers are present. Thus, PDT can be used to destroy diseased areas of tissue selectively, while sparing the normal surrounding tissue. PDT has been extensively studied in the treatment of cancer, but the technology has potential as a treatment in a number of other disease conditions.


8. DOCID:22360 SCORE: 0.00178387684110271
DOCNO: 8969552
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: complications
QUALIFIER: epidemiology
AUTHOR: T Miyamoto T
AUTHOR: Y Okuda Y
AUTHOR: T Oyama T
AUTHOR: H Oyama H
AUTHOR: K Takasugi K
AFFILIATION: Center for Rheumatic Diseases, Dohgo Spa Hospital, Matsuyama-city.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Ryūmachi. [Rheumatism].
COUNTRY: JAPAN
TITLE: [Incidence of cancer among Japanese patients with rheumatoid arthritis]
PUBDATE: 19961001
Most follow-up studies of patients with rheumatoid arthritis demonstrate no increase in the incidence of cancer apart from approximate doubling of the incidence of lymphoproliferative malignancies. A consecutive series of 1832 Japanese patients with rheumatoid arthritis seen at the center was studied to determine their cancer morbidity. Overall, 35 cancers were diagnosed in the series from 1982 through 1995 and were not significantly in excess of the expected number. No association was found between rheumatoid arthritis and subsequent development of cancer at any site, either.


9. DOCID:22724 SCORE: 0.00173047047340497
DOCNO: 8646603
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: pathology
QUALIFIER: pathology
AUTHOR: N Tsuboniwa N
AUTHOR: T Miki T
AUTHOR: M Kuroda M
AUTHOR: O Maeda O
AUTHOR: S Saiki S
AUTHOR: T Kinouchi T
AUTHOR: M Usami M
AUTHOR: T Kotake T
AFFILIATION: Department of Urology, Center of Adult Diseases, Osaka, Japan.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: International journal of urology : official journal of the Japanese Urological Association.
COUNTRY: JAPAN
TITLE: Primary adenocarcinoma in an ileal conduit.
PUBDATE: 19960101
Reports of primary small intestine malignancies are rare. Even more uncommon is primary carcinoma in an ileal conduit. Here, we report a case of primary adenocarcinoma in an ileal conduit that developed 14 years after radical cystectomy and diversion to an ileal conduit for transitional cell carcinoma of the bladder. To our knowledge, only one case of primary adenocarcinoma developing in an ileal conduit after a radical surgery for bladder cancer has been reported previously.


10. DOCID:22266 SCORE: 0.00171123533999236
DOCNO: 9104541
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: etiology
QUALIFIER: pathology
QUALIFIER: complications
QUALIFIER: pathology
AUTHOR: V Soroush V
AUTHOR: A W Gurevitch AW
AFFILIATION: UCLA School of Medicine, Harbor-UCLA Medical Center, Department of Medicine, Torrance 90509, USA.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Cutis; cutaneous medicine for the practitioner.
COUNTRY: UNITED STATES
TITLE: Darier's disease associated with multiple café-au-lait macules.
PUBDATE: 19970401
Darier's disease, or keratosis follicularis, is an autosomal dominant inherited skin disease characterized by keratotic papules predominantly on the upper trunk and scalp, palmar pits, and nail dystrophy. It has been reported in association with basal cell carcinoma and other skin cancers, neuropsychiatric disorders, salivary gland obstruction, renal and testicular agenesis, bone cysts, and psoriasis. We describe the first report of a patient with multiple café-au-lait macules, but no personal or family history of neurofibromatosis, who developed Darier's disease.


11. DOCID:23202 SCORE: 0.00162772576234391
DOCNO: 8052876
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: drug therapy
QUALIFIER: administration & dosage
QUALIFIER: drug therapy
AUTHOR: N van Zandwijk N
AUTHOR: O Dalesio O
AFFILIATION: Department of Pulmonary Oncology, The Netherlands Cancer Institute, Amsterdam.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Seminars in oncology.
COUNTRY: UNITED STATES
TITLE: Platinum-based chemotherapy in non-small cell lung cancer: the experience of the European Organization for the Research and Treatment of Cancer.
PUBDATE: 19940601
The history of chemotherapy for non-small cell lung carcinoma is one of very slow progress. Consequently, the categories of patients who will ultimately benefit from this modality are still debated. Recent European Organization for Research and Treatment of Cancer studies show that there is less concern about the importance of platinum as an ingredient of combination regimens or as an adjunct to radiotherapy. The presence of cisplatin is related to better response and survival in patients with locoregional and distant metastatic disease.


12. DOCID:23135 SCORE: 0.00162772575414758
DOCNO: 9052666
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: diagnosis
QUALIFIER: diagnosis
QUALIFIER: pathology
QUALIFIER: pathology
AUTHOR: J D Browne JD
AFFILIATION: Department of Otolaryngology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157, USA.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Otolaryngologic clinics of North America.
COUNTRY: UNITED STATES
TITLE: Management of nonepidermoid cancer of the larynx.
PUBDATE: 19970401
Nonepidermoid cancer of the larynx represents an extremely diverse group of diseases with differing prognoses and rationales of management. With the lack of specificity in symptoms and physical findings, proper and expeditious lesion characterization is therefore dependent on a high index of suspicion by the clinician and accurate consulting histopathology. These neoplasms can be grouped according to cells with secretory, connective tissue, lymphoreticular, or metastatic origins. Based upon this framework, this article discusses the unique aspects of these various diseases that can lead to their diagnosis, along with consideration of management options and prognostic variables.


13. DOCID:23159 SCORE: 0.00161807337998418
DOCNO: 8557253
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Chromosomes, Human, Pair 19
DESCRIPTOR: Polymorphism, Genetic
DESCRIPTOR: Repetitive Sequences, Nucleic Acid
QUALIFIER: genetics
AUTHOR: M R Kohonen-Corish MR
AUTHOR: Y Wang Y
AUTHOR: W F Doe WF
AFFILIATION: Division of Clinical Sciences, John Curtin School of Medical Research, Australian National University, Canberra, Australia.
PUBTYPE: Journal Article
JOURNALTITLE: Human genetics.
COUNTRY: GERMANY
TITLE: A highly polymorphic CA/GT repeat in intron 3 of the human urokinase receptor gene (PLAUR).
PUBDATE: 19960101
We describe the first highly polymorphic microsatellite marker for the human urokinase plasminogen activator receptor gene (PLAUR). The urokinase receptor (uPAR) has a central role in cancer invasion and metastasis, which may enable the development of new anti-metastatic therapies. Analysis of the marker genotypes in colorectal cancer cell lines revealed three alleles that were not detected in a series of healthy control individuals, which encourages further genetic study of the role of uPAR in cancer.


14. DOCID:23461 SCORE: 0.00158419822566921
DOCNO: 7880110
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: administration & dosage
QUALIFIER: drug therapy
QUALIFIER: drug therapy
AUTHOR: A Fujita A
AUTHOR: H Takabatake H
AUTHOR: S Tagaki S
AUTHOR: K Sekine K
AFFILIATION: Division of Respiratory Disease, Minami Ichijo Hospital.
PUBTYPE: Journal Article
JOURNALTITLE: Gan to kagaku ryoho. Cancer & chemotherapy.
COUNTRY: JAPAN
TITLE: [A pilot study of combination chemotherapy with cyclophosphamide, adriamycin, chronic daily dosing of oral etoposide for patients with SCLC ineligible for intensive chemotherapy]
PUBDATE: 19950201
Twenty-two patients with small cell lung cancer (SCLC) ineligible for intensive chemotherapy were treated with a combination of cyclophosphamide 800 mg/m2 iv day 1, adriamycin iv 40 mg/m2 day 1, and oral etoposide 40 mg/m2 once daily day 1-21. The overall response rate was 72.7% with 2 complete and 14 partial responders. The median survival time was 272 days in LD and 231 days in ED. The side effects were acceptable but not as mild as expected.